Find out what’s hitting the headlines in our pioneering dementia research and how your support is bringing us closer to a cure.
If you have a press enquiry please visit our Press Office page.
Brexit must not delay the development and delivery of the first life-changing treatment for people living with dementia. That was the message Alzheimer’s Research UK had for politicians today during a roundtable hosted by the Exiting the European Union Committee. The meeting, held in Cambridge this afternoon, brought together pharmaceutical companies and research organisations to […]
Alzheimer’s Research UK is calling for a recommitment from pharmaceutical companies to continue efforts to fund research into dementia, the leading cause of death in the UK. Recent news that Pfizer will refocus efforts away from dementia research is a reminder of one of the barriers that stands in the way of bringing about the […]
Deaths caused by dementia continue to rise across Scotland according to provisional figures released today by National Records of Scotland. The figures show deaths caused by Alzheimer’s and other dementias increased in the third quarter of 2017 by 13.6 per cent to 861. These deaths now account for 10 per cent of all deaths, doubled […]
Alzheimer’s Research UK is calling for a renewed global commitment to treating dementia following new data from the World Health Organization (WHO) released today. The figures predict the number of people living with the condition will triple from 50 million to 152 million by 2050. This falls in line with data for the UK, where […]
Alzheimer’s Research UK is asking the government to give more priority to dementia as plans develop to support the Life Sciences sector. The Sector Deal announced today (6 December) represents yet another step forward by government to establish the UK as a global leader in health research. However, Alzheimer’s Research UK, the UK’s leading dementia […]
Alzheimer’s Research UK, the UK’s leading dementia research charity, is calling on the government to protect dementia treatments as the NHS copes with future budget concerns. Reports in the media following yesterday’s NHS board meeting suggest that future treatments may be rationed due to budget constraints, including treatments for dementia, arthritis, hearing loss and blindness. […]
Alzheimer’s Research UK is asking the government to increase financial support for dementia research as part of its Industrial Strategy plans. The Industrial Strategy white paper launched today outlines a commitment to research and development and the life science sector, and emphasises the need to support an ageing population. Alzheimer’s Research UK, the UK’s leading […]
Alzheimer’s Research UK is calling on the government to make continued commitments that support world-class research to address dementia – the leading cause of death in the UK and most feared condition of people over the age of 55. This comes in the wake of today’s budget announcement of plans to support sector growth through […]
The US healthcare system is not ready for potential breakthrough dementia treatments according to a new Rand Corporation study released yesterday. The study, commissioned by US biotechnology company Biogen, looked at the capacity of the current system to integrate new treatments. Alzheimer’s Research UK, the UK’s leading dementia research charity, is warning that similar roadblocks […]
The Dementia Discovery Fund (DDF) today announces a $50 million investment from Bill Gates. The investment is Gates’ first to accelerate progress toward disease-modifying therapies for Alzheimer’s disease. The DDF, managed by SV Health, is a unique venture fund focused entirely on discovering and developing novel therapies for dementia and was formed through the collaboration […]